Delivery included to the United States

Cognitive Impairment in Major Depressive Disorder

Cognitive Impairment in Major Depressive Disorder Clinical Relevance, Biological Substrates, and Treatment Opportunities

Hardback (17 Mar 2016)

  • $159.68
Add to basket

Includes delivery to the United States

9 copies available online - Usually dispatched within 72 hours

Publisher's Synopsis

Major depressive disorder (MDD) is the leading cause of disability globally in both developed and developing nations. The staggering economic costs attributable to MDD are largely a consequence of impairment in role function. Evidence indicates that disturbance in the domain of cognitive function in individuals with MDD is the principal determinant of health outcome. This is the first book to comprehensively explore the domain of cognition in MDD. The literature describing cognitive dysfunction is reviewed with particular focus on clinical determinants, pathophysiology and causative factors. The patient subpopulations most susceptible are defined. A summary of contemporary assessment tools for research and clinical purposes is provided. Multimodality treatments and prevention strategies are described. This book is an invaluable resource for psychiatrists, neuropsychologists and other members of the mental health team, as well as for policy makers, vocation rehabilitation experts, disability providers and other stakeholders interested in improving health outcomes in MDD.

About the Publisher

Cambridge University Press

Cambridge University Press dates from 1534 and is part of the University of Cambridge. We further the University's mission by disseminating knowledge in the pursuit of education, learning and research at the highest international levels of excellence.

Book information

ISBN: 9781107074583
Publisher: Cambridge University Press
Imprint: Cambridge University Press
Pub date:
DEWEY: 616.8527
DEWEY edition: 23
Language: English
Number of pages: 370
Weight: 782g
Height: 165mm
Width: 241mm
Spine width: 21mm